Genome Web Breaking News
- Supercentenarians Have Increased Levels of Cytotoxic CD4 T Cells
- Exact Sciences Sues Johns Hopkins University for 'Improperly' Demanding Royalties
- NorthBay Healthcare to Pilot GenomeSmart Genetic Test Recommendation Platform
- Colorectal Cancer Study Reveals Gut Microbe, Methylation Shifts
- T2 Biosystems Q3 Revenues Drop 36 Percent; Firm Suffers Ransom Cyberattack
Stat
- STAT Plus: More Americans can’t afford prescriptions and most think Trump isn’t doing enough to help
- Former FDA commissioner calls for a full ban on pod-based e-cigarettes
- STAT Plus: Pharmalittle: Biotechs worry about Democrats’ drug pricing bill; PhRMA criticizes four countries over policies
- STAT Plus: FDA documents point to a broadened approval for Amarin’s heart pill Vascepa
- Solid Biosciences’ Duchenne gene therapy trial halted after patient suffers serious toxicity
NYT science news
- 5 Global Trends Shaping Our Climate Future
- Goodbye, America: Greta Thunberg to Sail Again After Climate Talks Relocate
- A Silicon Valley Disruption for Birds That Gorge on Endangered Fish
- If I Touched the Moon, What Would It Feel Like?
- Patient Care Is Wrenching: A Psychiatrist, a Nurse and a Doctor Bare All
Xconomy news
- NIBR’s Raman Departs for Chief Biz Dev Role at Flagship Pioneering
- Reata’s Kidney Drug Hits Goals of Key Study, Paves Way for FDA Filing
- FDA Again Halts Solid Bio’s Duchenne Gene Therapy Clinical Trial
- TransEnterix CEO Pope Steps Down, Fernando Appointed Successor
- Neurana Pharmaceuticals Appoints Randall Kaye Chief Medical Officer
Fierce Biotech
- Solid Bio sees yet another clinical hold for its DMD gene therapy
- AASLD: VBI Vaccines details hep B candidate as it preps 2020 filing
- Amgen to cut 149 staff in retreat from neuroscience R&D
- AASLD: Durect's alcoholic hepatitis med repairs liver, cuts mortality in phase 2
- AstraZeneca plans 2020 filing for anifrolumab in lupus
Fierce Medical Devices
- Invitae to buy DNA-counseling chatbot developer Clear Genetics for $50M
- AASLD: Gilead wants to move the needle for fatty liver therapies
- AHA: HDL Therapeutics' cholesterol-enriching procedure cuts coronary plaque in rare genetic disorder
- Siemens' newly acquired Corindus unit performs its first robotic brain aneurysm surgery
- 10x Genomics posts 67% growth in Q3, its first report since going public